Soon after families carve up the Thanksgiving turkey, the US IPO market will see its own large carve-outs. Spin-offs have been a recurring theme over the past couple years, and recent filings from ZEEKR (ZK) and UL Solutions (ULS) signal that the trend is set to continue. Compared to VC- or PE-backed deals, carve-out IPOs are more prevalent...read more
In what would be the largest US IPO since late 2021, Kenvue (KVUE) is slated to raise $3.3 billion, more than doubling YTD IPO proceeds. It's scheduled to begin trading this week. Being spun out of Johnson & Johnson, consumer health giant Kenvue is pitching a mature and profitable...read more
The IPO Market Flips from Boom to Bust in 2022 After the prior year’s record activity, the 2022 US IPO market ground to a halt as the war in Ukraine, a valuation correction in high-multiple stocks, historic interest rate hikes, and looming fears of a recession caused the narrowing IPO window to slam shut. 71...read more
While market conditions are still keeping the IPO window mostly closed, the year's large issuers are finding support, especially over the past few months. Excluding high-flying outlier HKD, just 15 IPOs have raised $100 million or more in 2022, and 13 (87%) are trading above issue. The group averages an impressive 29% return from offer, driven by... ...read more
IPO investors crave carve-outs with 2 more teed up after Thanksgiving
Soon after families carve up the Thanksgiving turkey, the US IPO market will see its own large carve-outs. Spin-offs have been a recurring theme over the past couple years, and recent filings from ZEEKR (ZK) and UL Solutions (ULS) signal that the trend is set to continue. Compared to VC- or PE-backed deals, carve-out IPOs are more prevalent...read more
Kenvue is the IPO market's latest spin-off; here's how past spin-offs have performed alongside former parents
In what would be the largest US IPO since late 2021, Kenvue (KVUE) is slated to raise $3.3 billion, more than doubling YTD IPO proceeds. It's scheduled to begin trading this week. Being spun out of Johnson & Johnson, consumer health giant Kenvue is pitching a mature and profitable...read more
Updated: Renaissance Capital's 2022 US IPO Market Review
The IPO Market Flips from Boom to Bust in 2022 After the prior year’s record activity, the 2022 US IPO market ground to a halt as the war in Ukraine, a valuation correction in high-multiple stocks, historic interest rate hikes, and looming fears of a recession caused the narrowing IPO window to slam shut. 71...read more
Nearly 90% of 2022's large IPOs are trading above issue
While market conditions are still keeping the IPO window mostly closed, the year's large issuers are finding support, especially over the past few months. Excluding high-flying outlier HKD, just 15 IPOs have raised $100 million or more in 2022, and 13 (87%) are trading above issue. The group averages an impressive 29% return from offer, driven by... ...read more